No. Founders and early employees should really never receive anti-dilution promises as part of their initial grants. Instead, the company should figure out the right number of shares to grant the employee from the start.
If the startup issues shares to new investors in a financing, the employee’s existing shares will be worth more. The shares will be diluted but become more valuable.1 Scroll through Venture Dealr for a visual explanation. In short, the employee’s equity percentage doesn’t have to remain the same for the employee to reap the benefits of the financing. The number of shares she has after the financing will be worth significantly more as a result of the new investment. Employees will benefit from a financing even without anti-dilution rights.
If a startup grants anti-dilution rights to an employee, it will run into problems when future investors find out. Investors will likely refuse to invest unless the employee’s anti-dilution guarantee is removed. At that point, the employee will hold some significant leverage over the term sheet negotiation.
Employee anti-dilution is problematic. It adds unnecessary complication, deters investors, and may give the employee undue influence over a financing. If an employee demands anti-dilution rights, there is a good chance that they simply don’t understand the mechanics of issuing stock in a financing. Walking them through the benefits may change their mind and help you make the hire.
Two more comments:
One situation where it may make sense to grant anti-dilution protection to an employee is when a board brings in an outside CEO close to a financing round, and is expecting the CEO to facilitate that financing round soon after he joins. But even in those cases, most boards should instead grant the CEO an appropriate grant with the expectation that the next financing round would occur shortly after, and the CEO would be diluted along with everyone else.
Investors may demand anti-dilution rights to protect against a down round. (e.g., they mistakenly overvalued the company in a Series A, and when they discover this in the Series B, they want to get some extra shares to make up for their initial overpayment). Investor anti-dilution rights only kick in during a down-round, not a normal financing.
Unless it’s a down round. ↩